{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T07:18:53Z","timestamp":1783149533781,"version":"3.54.6"},"reference-count":34,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K16288"],"award-info":[{"award-number":["23K16288"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jiac.2026.103004","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T15:58:46Z","timestamp":1780070326000},"page":"103004","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cefmetazole or flomoxef versus carbapenems in treating patients with extended-spectrum \u03b2-lactamase-producing Enterobacterales bacteremia: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0470-5804","authenticated-orcid":false,"given":"Haruka","family":"Imai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8913-1864","authenticated-orcid":false,"given":"Jun","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0487-7147","authenticated-orcid":false,"given":"Tomoki","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1170-8595","authenticated-orcid":false,"given":"Shota","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideya","family":"Itagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0045-1720","authenticated-orcid":false,"given":"Tomohiro","family":"Akaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makiko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0103-415X","authenticated-orcid":false,"given":"Shiro","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2026.103004_bib1","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1128\/AAC.50.4.1257-1262.2006","article-title":"Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae","volume":"50","author":"Schwaber","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2026.103004_bib2","article-title":"Infectious diseases society of America 2024 guidance on the treatment of antimicrobial-resistant Gram-negative infections","volume":"2024","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.jiac.2026.103004_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s40121-015-0081-y","article-title":"Considerations about antimicrobial stewardship in settings with epidemic extended-spectrum \u03b2-lactamase-producing or carbapenem-resistant enterobacteriaceae","volume":"4","author":"Viale","year":"2015","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.jiac.2026.103004_bib4","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.diagmicrobio.2015.10.008","article-title":"Emerging trends in epidemiology and management of infections caused by carbapenem-resistant enterobacteriaceae","volume":"85","author":"Martirosov","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2026.103004_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2024.127839","article-title":"Hypervirulent and carbapenem-resistant Klebsiella pneumoniae: a global public health threat","volume":"288","author":"Lei","year":"2024","journal-title":"Microbiol Res"},{"key":"10.1016\/j.jiac.2026.103004_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00079-17","article-title":"Treatment of infections caused by extended-spectrum-beta-lactamase-, AmpC-, and carbapenemase-producing enterobacteriaceae","volume":"31","author":"Rodr\u00edguez-Ba\u00f1o","year":"2018","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jiac.2026.103004_bib7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3390\/antibiotics9020061","article-title":"Carbapenem-sparing strategies for ESBL producers: when and how","volume":"9","author":"Karaiskos","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.jiac.2026.103004_bib8","first-page":"502","article-title":"Clinical and microbiological evaluation of extended-spectrum \u03b2-lactamase producing Escherichia coli bacteremia","volume":"57","author":"Yamaguchi","year":"2009","journal-title":"J Jpn Soc Chemother"},{"key":"10.1016\/j.jiac.2026.103004_bib9","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/1471-2334-12-206","article-title":"Discrepancy between effects of carbapenems and flomoxef in treating nosocomial hemodialysis access-related bacteremia secondary to extended spectrum beta-lactamase producing Klebsiella pneumoniae in patients on maintenance hemodialysis","volume":"12","author":"Yang","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2026.103004_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijid.2014.07.012","article-title":"Nosocomial extended-spectrum beta-lactamase-producing Klebsiella pneumoniae bacteremia in hemodialysis patients and the implications for antibiotic therapy","volume":"28","author":"Yang","year":"2014","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiac.2026.103004_bib11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2147\/IDR.S146923","article-title":"Clinical benefit of ertapenem compared to flomoxef for the treatment of cefotaxime-resistant Enterobacteriaceae bacteremia","volume":"11","author":"Chen-Hsiang","year":"2018","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jiac.2026.103004_bib12","doi-asserted-by":"crossref","DOI":"10.1128\/aac.00510-23","article-title":"Effectiveness of cefmetazole versus meropenem for invasive urinary tract infections caused by extended-spectrum \u03b2-lactamase-producing Escherichia coli","volume":"67","author":"Hayakawa","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2026.103004_bib13","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.ijantimicag.2015.07.020","volume":"46","author":"Lee","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2026.103004_bib14","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1128\/AAC.00701-15","article-title":"Multicenter retrospective study of cefmetazole and flomoxef for treatment of extended-spectrum-\u03b2-lactamase-producing Escherichia coli bacteremia","volume":"59","author":"Matsumura","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2026.103004_bib15","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s12879-016-1770-1","article-title":"Cefmetazole for bacteremia caused by ESBL-producing enterobacteriaceae comparing with carbapenems","volume":"16","author":"Fukuchi","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2026.103004_bib16","first-page":"605","article-title":"Clinical and economic impact of de-escalation to cefmetazole on the treatment of bacteremia caused by extended-spectrum beta-lactamase producing Enterobacterales","volume":"59","author":"Izumi","year":"2023","journal-title":"J Jpn Soc Hosp Pharm"},{"key":"10.1016\/j.jiac.2026.103004_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad502","article-title":"Efficacy and safety of cefmetazole for bacteremia caused by extended-spectrum \u03b2-lactamase-producing Enterobacterales vs carbapenems: a retrospective study","volume":"10","author":"Kashihara","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.jiac.2026.103004_bib18","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1515\/med-2020-0103","article-title":"Successful de-escalation antibiotic therapy using cephamycins for sepsis caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae bacteremia: a sequential 25-case series","volume":"15","author":"Kuwana","year":"2020","journal-title":"Open Med"},{"key":"10.1016\/j.jiac.2026.103004_bib19","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.2169\/internalmedicine.56.7702","article-title":"Clinical characteristics of bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli at a tertiary hospital","volume":"56","author":"Namikawa","year":"2017","journal-title":"Intern Med"},{"key":"10.1016\/j.jiac.2026.103004_bib20","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s13104-017-2680-z","article-title":"Bacteraemic urinary tract infections in a tertiary hospital in Japan: the epidemiology of community-acquired infections and the role of non-carbapenem therapy","volume":"10","author":"Mawatari","year":"2017","journal-title":"BMC Res Notes"},{"issue":"1105","key":"10.1016\/j.jiac.2026.103004_bib21","first-page":"e1","article-title":"Clinical and microbiologic characteristics of adult patients with recurrent bacteraemia caused by extended-spectrum \u03b2-lactamase-producing Escherichia coli or Klebsiella pneumoniae","volume":"21","author":"Lee","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2026.103004_bib22","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jiac.2026.103004_bib23","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1086\/519283","article-title":"A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients","volume":"45","author":"McGregor","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2026.103004_bib24","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s12879-016-1650-8","article-title":"Effects of inappropriate empirical antibiotic therapy on mortality in patients with healthcare-associated methicillin-resistant Staphylococcus aureus bacteremia: a propensity-matched analysis","volume":"16","author":"Yoon","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jiac.2026.103004_bib25","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jclinepi.2012.09.016","article-title":"Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity","volume":"66","author":"Kim","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jiac.2026.103004_bib26","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software 'EZR' for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jiac.2026.103004_bib27","first-page":"2258","article-title":"[Statistical analysis using freely-available \"EZR (Easy R)\" software]","volume":"56","author":"Kanda","year":"2015","journal-title":"Rinsho Ketsueki"},{"key":"10.1016\/j.jiac.2026.103004_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0924-8579(98)00060-0","article-title":"Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary","volume":"11","author":"Chow","year":"1999","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2026.103004_bib29","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/BF01709751","article-title":"The SOFA (Sepsis-related organ failure assessment) score to describe organ dysfunction\/failure","volume":"22","author":"Vincent","year":"1996","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jiac.2026.103004_bib30","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jiac.2026.103004_bib31","article-title":"Risk and prognosis of bloodstream infections among patients on chronic hemodialysis: a population-based cohort study","volume":"10","author":"Skov","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jiac.2026.103004_bib32","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3390\/microorganisms14010230","article-title":"Characteristics of infections in hemodialysis patients: results from a single-center 29-month observational cohort study from Romania","volume":"14","author":"Birlutiu","year":"2026","journal-title":"Microorganisms"},{"key":"10.1016\/j.jiac.2026.103004_bib33","doi-asserted-by":"crossref","first-page":"9785","DOI":"10.1038\/s41598-025-90762-1","article-title":"Antimicrobial activity of cephamycins and \u03b2-lactam\/\u03b2-lactamase inhibitors against ESBL-producing Escherichia coli and Klebsiella pneumoniae under standard and high bacterial inocula","volume":"15","author":"Wi","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiac.2026.103004_bib34","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1093\/jac\/dkz226","article-title":"Inoculum effect of \u03b2-lactam antibiotics","volume":"74","author":"Lenhard","year":"2019","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26001029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X26001029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T06:53:28Z","timestamp":1783148008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X26001029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S1341321X26001029"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2026.103004","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cefmetazole or flomoxef versus carbapenems in treating patients with extended-spectrum \u03b2-lactamase-producing Enterobacterales bacteremia: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2026.103004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103004"}}